ReviewESMO real world data and digital oncology2026
Real-world evidence for the postmarket surveillance of cancer medicines: opportunities and challenges using Australia's population-based cancer registries.
B Daniels et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.